Source: Annual Congress 2013 –Pneumonia and sepsis
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
L. Haste, K. Hulland, K. McKechnie, P. Andrew (Leicester, Loughborough, United Kingdom). Chronic pulmonary infection with streptococcus pneumoniae during ovalbumin allergic inflammation. Eur Respir J 2013; 42: Suppl. 57, 295

Member's Comments

No comment yet.

Related content which might interest you: Alteration of the immune response to streptococcus pneumoniae during COPD exacerbation in mice Source: Annual Congress 2013 –COPD and infections Year: 2013 Cellular and physiological characterisation of a murine model of long-term pulmonary infection with streptococcus pneumoniae Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013 Intranasal administration of lipopolysaccharide (LPS) during a chronic pulmonary infection with streptococcus pneumoniae resulted in a synergistic effect on neutrophil influx in mice Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections Year: 2014 Chronic pseudomonas aeruginosa airway infection induces peribronchial lymphoid neogenesis in mice Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung Year: 2013 Associations between sensitization to Staphylococcus aureus enterotoxins and Th2/eosinophilic inflammation and uncontrolled asthma Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Crucial timing of a viral component exposure to exacerbate allergen-induced asthma Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016 Establishment of a murine asthma exacerbation model by combining OVA exposure with either RSV or influenza infection Source: International Congress 2016 – Immune responses in the lung Year: 2016 The effect of lipopolysaccharide-contaminated ovalbumin on airway inflammation and remodeling in a chronic murine asthma model Source: Annual Congress 2013 –Murine models of lung immunology Year: 2013 Influenza induced exacerbation is associated with steroid insensitive AHR and pulmonary inflammation in HDM-sensitised mice Source: International Congress 2016 – Immune responses in the lung Year: 2016 Chlamydia pneumoniae immunoglobulin A reactivation and airway inflammation in acute asthma Source: Eur Respir J 2002; 20: 834-840 Year: 2002 Influenza but not rhinovirus viral strain causes exacerbation of a house dust mite driven severe asthma mouse model Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014 The effect of influenza virus infection on airway inflammation in a murine model of asthma Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013 Streptococcus pneumoniae infection suppresses allergic airways disease by inducing regulatory T-cells Source: Eur Respir J 2011; 37: 53-64 Year: 2011 Uncontrolled asthma in children: The role M. pneumoniae and Cl. pneumoniae Source: Annual Congress 2013 –Uncontrolled and severe asthma in children Year: 2013 Characteristics of IL-25 and allergen-induced airways fibrosis in a murine model of asthma Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 Alteration of the immune response to nontypeable haemophilus influenzae (NTHI) during COPD exacerbation in mice Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013 IL33 and TSLP involvements in influenza-induced exacerbation in a murine model of chronic asthma Source: International Congress 2015 – Advances in asthma and allergy in animal models Year: 2015 Tiotropium attenuates pulmonary inflammation in a novel mouse smoke RSV re-infection model Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections Year: 2014 Broad spectrum of virulence of pseudomonas aeruginosa clones characterized in a murine airway infection model Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013 Treatment with Syk inhibitors after establishment of disease phenotype in a chronic HDM model of allergic airways inflammation abolishes AHR and attenuates inflammatory mediator expression Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015